Schedule 13G ownership disclosure

CATABASIS PHARMACEUTICALS IN

Security class unavailable · CUSIP: 14875P107

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001546927-16-000384
Form type
SC 13G/A
Filer
Astria Therapeutics, Inc.
CIK
CIK 1454789
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub